DataMEDS AI Statistics
Total Valuation
DataMEDS AI has a market cap or net worth of $8.98 million. The enterprise value is $37.66 million.
| Market Cap | 8.98M |
| Enterprise Value | 37.66M |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DataMEDS AI has 2.51 million shares outstanding. The number of shares has increased by 71.58% in one year.
| Current Share Class | 2.51M |
| Shares Outstanding | 2.51M |
| Shares Change (YoY) | +71.58% |
| Shares Change (QoQ) | +8.34% |
| Owned by Insiders (%) | 59.12% |
| Owned by Institutions (%) | 3.77% |
| Float | 614,460 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -79.18% |
| Return on Invested Capital (ROIC) | -159.60% |
| Return on Capital Employed (ROCE) | 2,697.11% |
| Weighted Average Cost of Capital (WACC) | 15.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.32 |
| Inventory Turnover | 3.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.93% in the last 52 weeks. The beta is 2.17, so DataMEDS AI's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | -93.93% |
| 50-Day Moving Average | 3.79 |
| 200-Day Moving Average | 14.90 |
| Relative Strength Index (RSI) | 56.05 |
| Average Volume (20 Days) | 49,029 |
Short Selling Information
The latest short interest is 15,001, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 15,001 |
| Short Previous Month | 23,078 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 2.44% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, DataMEDS AI had revenue of $14.03 million and -$76.59 million in losses. Loss per share was -$45.50.
| Revenue | 14.03M |
| Gross Profit | -6.95M |
| Operating Income | -55.86M |
| Pretax Income | -76.59M |
| Net Income | -76.59M |
| EBITDA | -53.10M |
| EBIT | -55.86M |
| Loss Per Share | -$45.50 |
Balance Sheet
The company has $51,730 in cash and $28.73 million in debt, with a net cash position of -$28.68 million or -$11.43 per share.
| Cash & Cash Equivalents | 51,730 |
| Total Debt | 28.73M |
| Net Cash | -28.68M |
| Net Cash Per Share | -$11.43 |
| Equity (Book Value) | -15.06M |
| Book Value Per Share | -6.32 |
| Working Capital | -29.44M |
Cash Flow
| Operating Cash Flow | -12.92M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.77M |
| Net Borrowing | 810,892 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -49.51% |
| Operating Margin | -398.05% |
| Pretax Margin | -545.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DataMEDS AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.58% |
| Shareholder Yield | -71.58% |
| Earnings Yield | -852.50% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 26, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
DataMEDS AI has an Altman Z-Score of -11.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.32 |
| Piotroski F-Score | 1 |